SEC Form 4 · accession 0001445064-15-000141
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance L Carlson
Officer — Interim General Counsel
Period of report
Nov 27, 2015
Accepted (ET)
Dec 1, 2015 · 9:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 27, 2015 | P | 1,000 | $66.5399 | A | 1,453 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 453 shares acquired between August 5 and November 9, 2015, under the Mallinckrodt employee stock purchase plan.